Key facts for Q0166
- Billing unit
- 1 MG
- Granisetron hcl 1 mg oral
- ASP payment limit
- $0.774
- October 2026
- Practitioner MUE
- 0
- MAI 3
- OPPS status
- SI N
- NCCI exposure
- no PTP pairs
- Coverage articles
- 0
- none list this code
TL;DR
HCPCS Q0166 is the Level II code for Granisetron hydrochloride, 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 24 hour dosage regimen, billed per 1 MG. The Medicare Part B ASP payment limit for October 2026 is $0.774 per billing unit. The practitioner MUE allows up to 0 units per date of service (MAI 3). Under OPPS it carries status indicator N. Oral drugs under Part B are payable only in the specific statutory categories (for example oral anticancer or antiemetic drugs with a self-administration exception), so the diagnosis and the regimen must match that category. With a 1 mg billing unit, a single administration can be hundreds of units; the unit count on the claim must equal the milligrams given, and rounding rules for partial units follow the contractor's guidance. Other HCPCS codes whose descriptor names granisetron: J1626 (billed per 100 mcg); J1627 (Sustol from Heron Therapeutics; extended-release; billed per 0.1 mg). The ASP crosswalk maps 2 NDCs to it, sold as Granisetron HCl by Breckenridge Pharmaceutical, Inc. No current Billing and Coding Article lists Q0166, so coverage follows the FDA label, compendia and any applicable NCD.
Medicare Part B payment limit (ASP)
CMS sets the Part B payment limit for Q0166 at $0.774 per 1 MG for October 2026, derived from manufacturer average sales price plus 6%. Beneficiary coinsurance is 20%.
| Quarter | Payment limit | Per | Coinsurance |
|---|---|---|---|
| October 2026 | $0.774 | 1 MG | 20% |
| July 2026 | n/a | 1 MG | — |
NDC to HCPCS billing-unit conversion
The October 2026 ASP crosswalk maps 2 NDCs from 1 labeler to Q0166. Report the NDC in the claim's drug segment and bill the number of Q0166 units that equals the quantity administered divided by 1 MG; the last column gives units per full package.
| NDC | Drug name | Labeler | Package size | Billing units / package |
|---|---|---|---|---|
| 51991-0735-20 | Granisetron HCl | Breckenridge Pharmaceutical, Inc. | 20 × 1 | 20 |
| 51991-0735-32 | Granisetron HCl | Breckenridge Pharmaceutical, Inc. | 2 × 1 | 2 |
Medically Unlikely Edits (MUE)
CMS publishes 3 MUE values for Q0166. For practitioners the limit is 0 units per date of service with adjudication indicator 3, a date-of-service clinical edit: units above the limit deny but can be paid on appeal with documentation that the quantity was medically reasonable.
| Setting | MUE (units/DOS) | MAI | CMS rationale |
|---|---|---|---|
| Practitioner services | 0 | 3 Date of Service Edit: Clinical | Oral Medication; Not Payable |
| Facility outpatient hospital | 2 | 3 Date of Service Edit: Clinical | Prescribing Information |
| DME supplier | 2 | 3 Date of Service Edit: Clinical | Prescribing Information |
MUE for Q0166 in every setting opens the lookup with this code filled in, next to any other code on the same claim.
Medicaid NCCI differs: the 2026 Q4 Medicaid MUE for Q0166 is 2 units for practitioner claims (Medicare: 0). Compare both programs in the MUE lookup or read how Medicaid NCCI differs from Medicare.
NCCI edits and add-on relationships
No active practitioner PTP pair lists Q0166 as a column-1 or column-2 code in v323r0. Drug supply codes are rarely bundled; the administration codes billed with them are where PTP edits usually apply.
The counts above are exposure, not answers for a specific claim. Check Q0166 against another code to see whether a given pair bundles, which code is paid and whether a modifier can separate them.
Q0166 is neither an add-on code nor a designated primary code in the 2026 Q4 NCCI add-on edit file.
Medicare coverage articles
No current Billing and Coding Article lists Q0166 in its HCPCS table. Coverage then follows the drug's FDA label, compendia and any National Coverage Determination; check the Medicare Coverage Database before administering off-label.
Local coverage policies that list Q0166
1 active Local Coverage Determination lists Q0166 in the policy or in its billing and coding article. Each applies only in its contractor's jurisdiction; check the one for the state where the drug is administered.
- LCD L33827: Oral Antiemetic Drugs (Replacement for Intravenous Antiemetics) · CGS Administrators, LLC; Noridian Healthcare Solutions, LLC
Hospital outpatient (OPPS) status
In the October 2026 OPPS Addendum B, Q0166 carries status indicator N. Status N means payment is packaged into the associated procedure and no separate OPPS payment is made.
Ambulatory surgical center (ASC) payment
In the October 2026 ASC Addendum BB (covered ancillary services), Q0166 carries payment indicator N1, which CMS defines as "Packaged service/item; no separate payment made". An N1 drug is packaged in the ASC: the facility receives no separate payment because the surgical procedure's rate already includes it.
Common denials for Q0166 and how to prevent them
For teams evaluating QuickIntell software
Evaluate a coding workflow for Q0166
Use the unit, NDC and edit questions in this reference to scope a QuickCode evaluation for qualified coder review, documentation clarification and the billing handoff. Confirm supported code sets, data inputs and reviewer responsibilities; the reference tables do not establish that a particular automated check or payer integration is available.
Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.
In QuickIntell research
- October 2026 ASP movers report: Q0166 is priced in the ASP file for the first time in October 2026.
- J codes by drug name: Every code for the same drug, generic or brand, in one A-Z index.
Frequently asked questions — HCPCS Q0166
What does HCPCS code Q0166 describe?
Q0166 is defined by CMS as "Granisetron hydrochloride, 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 24 hour dosage regimen". Each billing unit represents 1 MG, so the units reported on the claim must equal the dose administered divided by that unit.
Is Q0166 a CPT code?
No. Q0166 is a HCPCS Level II code, the letter-plus-four-digit set CMS maintains for drugs such as granisetron hydrochloride; CPT codes are five-character codes maintained by the AMA. On a Part B claim Q0166 reports the drug itself in 1 mg units, and the administration is billed on its own line.
What is the Medicare reimbursement for Q0166 in October 2026?
The ASP-based payment limit is $0.774 per 1 MG, with 20% beneficiary coinsurance. Commercial payers use their own fee schedules.
How many units of Q0166 can be billed per day?
The practitioner Medically Unlikely Edit is 0 units per date of service with adjudication indicator 3 (Date of Service Edit: Clinical). The facility outpatient MUE is 2. MAI 3 edits can be appealed with documentation that the units were medically reasonable. CMS cites "Oral Medication; Not Payable" as the rationale.
Which NDCs map to Q0166?
The October 2026 ASP crosswalk lists 2 NDCs from 1 labeler: Granisetron HCl (Breckenridge Pharmaceutical, Inc.). For example NDC 51991-0735-20 (package size 20) equals 20 billing units of Q0166.
Does Q0166 have NCCI bundling edits?
No active practitioner PTP pairs list Q0166 as a column-1 or column-2 code in the v323r0 release.
Q0166 vs J1626: what is the difference?
Both are HCPCS Level II codes whose descriptor names granisetron hydrochloride. What sets J1626 apart: billed per 100 mcg. Q0166 is billed per 1 mg, limit $0.774, MUE 0; J1626 is billed per 100 mcg, limit $0.16, MUE 30. Report the code whose descriptor matches the product and setting in the record.
Q0166 vs J1627: what is the difference?
Both are HCPCS Level II codes whose descriptor names granisetron. What sets J1627 apart: Sustol from Heron Therapeutics; extended-release; billed per 0.1 mg. Q0166 is billed per 1 mg, limit $0.774, MUE 0; J1627 is billed per 0.1 mg, limit $2.907, MUE 100. Report the code whose descriptor matches the product and setting in the record.
Sources
Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.
- HCPCS Level II alpha-numeric file, October 2026Version October 2026 · effective 2026-10-01 · file HCPC2026_OCT_ANWEB_09232026.txtSHA-256 c25240c63108756d…
- Medicare Part B Drug Payment Limit File, October 2026Version October 2026 · effective 2026-10-01 · file section 508 version of October 2026 Medicare Part B Payment Limit File 091626.csvSHA-256 508fba376a29e099…
- Medicare Part B Drug Payment Limit File, July 2026Version July 2026 · effective 2026-07-01 · file section 508 version of July 2026 Medicare Part B Payment Limit File updated 082026.csvSHA-256 13bb5b644b92b574…
- ASP NDC-HCPCS Crosswalk, October 2026Version October 2026 · effective 2026-10-01 · file section 508 version of October 2026 ASP NDC-HCPCS Crosswalk 091126.csvSHA-256 5cb78f0c2ee786ba…
- NCCI MUE table, practitioner services, effective 2026-10-01Version 2026 Q4 · effective 2026-10-01 · file MCR_MUE_PractitionerServices_Eff_10-01-2026.csvSHA-256 ef038efaf902b7bd…
- NCCI MUE table, facility services, effective 2026-10-01Version 2026 Q4 · effective 2026-10-01 · file MCR_MUE_OutpatientHospitalServices_Eff_10-01-2026.csvSHA-256 3af9f4e99cc587e2…
- NCCI MUE table, dme services, effective 2026-10-01Version 2026 Q4 · effective 2026-10-01 · file MCR_MUE_DMESupplierServices_Eff_10-01-2026.csvSHA-256 6fa4fbba852f7b74…
- NCCI PTP edits, practitioner, v323r0 (four files)Version v323r0 (2026 Q4) · effective 2026-10-01 · file ccipra-v323r0-f1.TXTSHA-256 7793c0b6686c1e22…
- NCCI Add-On Code edits, effective 2026-10-01Version 2026 Q4 · effective 2026-10-01 · file AOC_V2026Q4-F-MCR.xlsxSHA-256 eabb519623134549…
- OPPS Addendum B, October 2026Version October 2026 · effective 2026-10-01 · file 508-compliant-version-2026_October_Web_Addendum_B.09.28.26.csvSHA-256 6ad7393a318bf1b9…
- ASC Addendum BB (covered ancillary services), October 2026Version October 2026 · effective 2026-10-01 · file Oct 2026 ASC BB.txtSHA-256 63cdd7c72aba7a25…
- Medicare Coverage Database, current Billing and Coding Articles exportVersion MCD release 2026-11-12 · effective 2026-11-08 · file article.csvSHA-256 b475751458564786…
Disclaimer
This page is an operational reference compiled from CMS publications: the Medicare Part B drug payment limit and NDC crosswalk files, NCCI MUE and add-on edit tables, aggregate PTP statistics, OPPS Addendum B, ASC Addendum BB and the Medicare Coverage Database. Payment limits and rates are Medicare national amounts; commercial and Medicaid payers differ. CPT codes are shown as numbers only; CPT descriptors are copyright AMA. Nothing here is legal, clinical or billing advice.
Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.